Hypertension is an independent risk factor of cardiovascular and cerebrovascular diseases. Because of the genetic variation in drug-related metabolic enzymes and receptors, people may have different responses towards drugs used in hypertension treatment, which are very common in clinical practice.
This product is used for in vitro qualitative detection of CYP2D6*10, CYP2C9*3, ADRB1(1165G>C), AGTR1(1166A>C), ACE(I/D) in DNA extracted from peripheral blood of hypertensive patients.